Monograph: Optimizing Patient Care in Psoriasis and Psoriatic Arthritis: Integrating Management to Improve Outcomes

This monograph is a supplement to the JAAPA March 2022 issue. Psoriasis and psoriatic arthritis (PsA) are chronic inflammatory diseases that can substantially undermine the functional abilities and quality of life of affected individuals. Psoriasis is the most prevalent autoimmune disease in the United States, affecting more than 8 million Americans. The most common subtype is plaque psoriasis, which accounts for 80% to 90% of cases. Patients with psoriasis may find it difficult to perform usual activities of daily living, particularly when psoriatic lesions are present on the hands and feet. The physical toll of psoriasis can lead to problems such as fatigue, sleep disturbances, and reduced performance at work. Moreover, the toll on daily life often causes emotional difficulties arising from feelings of shame, embarrassment, and stress, which can lead to social isolation. Patients are also at risk for a variety of comorbid conditions, among which metabolic syndrome and cardiovascular disease (CVD) are of particular concern. In spite of the marked impact of psoriasis and PsA on patients’ lives, these conditions continue to be underdiagnosed and undertreated. PAs have pivotal opportunities to improve the care of patients with psoriasis and PsA through improved knowledge of clinical presentations, diagnostic approaches, treatment strategies, and management of comorbidities.

Learning Objectives

At the conclusion of this activity, the PA should be better able to: 

  • Assess patients presenting with symptoms of psoriasis and psoriatic arthritis and utilize appropriate testing to support the evaluation
  • Integrate patient specific clinical information to categorize disease severity
  • Formulate patient specific treatment plans for the management of psoriasis and psoriatic arthritis by incorporating currently available data and guideline recommendations
  • Evaluate patients with psoriasis and psoriatic arthritis for common comorbidities and facilitate comprehensive patient care
  • Implement effective strategies for the use of telemedicine in patient management

Acknowledgement of Commercial Support

This activity is supported by an independent educational grant from Amgen, Inc. and UCB, Inc.